Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors

DOI: 10.1080/2162402X.2018.1450711

Keywords: cancer immunotherapy, B lymphocytes, PD1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text